HPV-positive and HPV-negative head and neck squamous cell carcinoma (HNSCC) are recognized as distinct entities. There remains uncertainty surrounding the causal effects of smoking and alcohol on the development of these two cancer types. Here we perform multivariable Mendelian randomization (MR) to evaluate the causal effects of smoking and alcohol on the risk of HPV-positive and HPV-negative HNSCC in 3431 cases and 3469 controls. Lifetime smoking exposure, as measured by the Comprehensive Smoking Index (CSI), is associated with increased risk of both HPV-negative HNSCC (OR = 3.03, 95%CI:1.75-5.24, P = 7.00E-05) and HPV-positive HNSCC (OR = 2.73, 95%CI:1.39-5.36, P = 0.003). Drinks Per Week is also linked with increased risk of both HPV-negative HNSCC (OR = 7.72, 95%CI:3.63-16.4, P = 1.00E-07) and HPV-positive HNSCC (OR = 2.66, 95%CI:1.06-6.68, P = 0.038). Smoking and alcohol independently increase the risk of both HPV-positive and HPV-negative HNSCC. These findings have important implications for understanding the modifying risk factors between HNSCC subtypes.

Cancer Epidemiology Research Programme Catalan Institute of Oncology L'Hospitalet de Llobregat Barcelona Spain; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública Madrid Spain

Cancer Surveillance Branch International Agency for Research on Cancer World Health Organization Lyon France

Dalla Lana School of Public Health University of Toronto Toronto Ontario Canada

Department of Biostatistics Princess Margaret Cancer Centre University Health Network University of Toronto Toronto Ontario Canada

Department of Epidemiological Methods and Etiological Research Leibniz Institute for Prevention Research and Epidemiology BIPS Bremen Germany; Department of Mathematics and Computer Science University of Bremen Bremen Germany

Department of Epidemiology and Biostatistics University of Western Ontario London Ontario Canada

Department of Epidemiology University of North Carolina Chapel Hill North Carolina USA

Department of Human Genetics School of Public Health University of Pittsburgh and UPMC Hillman Cancer Center Pittsburgh PA 15260 USA

Department of Hygiene Epidemiology and Medical Statistics Medical School National and Kapodistrian University of Athens Goudi Greece

Department of Medical Sciences University of Turin and CPO Piemonte Turin Italy

Department of Oral and Maxillofacial Surgery Oral Medicine and Oral Pathology Dublin Dental University Hospital Trinity College Dublin Dublin Ireland

Department of Otolaryngology Head and Neck Surgery Sinai Health System Toronto Ontario Canada

Department of Otolaryngology Head and Neck Surgery University of Toronto Toronto Ontario Canada

Department of Psychiatry Washington University School of Medicine St Louis MO USA

Department of Public and Community Health School of Public Health University of West Attica Athens Greece

Department of Radiation Oncology University of Toronto Toronto Ontario Canada

Department of Research Cancer Registry of Norway Norwegian Institute of Public Health Oslo Norway

Division of Medical Oncology and Center for Cancer Research University of Tennessee Health Science Center Memphis TN USA

Division of Medical Oncology and Hematology Department of Medicine University of Toronto Toronto Ontario Canada

Epidemiology Group School of Medicine Medical Sciences and Nutrition University of Aberdeen Aberdeen UK

Genomic Epidemiology Branch International Agency for Research on Cancer World Health Organization Lyon France

Infections and Cancer Epidemiology German Cancer Research Center Heidelberg Germany

Institute of Hygiene and Epidemiology 1st Faculty of Medicine Charles University Prague Czech Republic

MRC Integrative Epidemiology Unit Population Health Sciences Bristol Medical School University of Bristol Bristol BS8 1TL UK

Princess Margaret Cancer Centre University Health Network Toronto Ontario Canada

Prosserman Centre for Population Health Research Lunenfeld Tanenbaum Research Institute Sinai Health Toronto Canada

School of Medicine Dentistry and Nursing University of Glasgow Glasgow UK

Unit of Cancer Epidemiology Centro di Riferimento Oncologico di Aviano IRCCS Aviano Italy

University Hospitals Bristol and Weston NHS Foundation Trust National Institute for Health Research Bristol Biomedical Research Centre University of Bristol Bristol BS1 3NU UK

University of Bristol Dental School 1 Trinity Walk Avon Street Bristol BS2 0PT UK

University of Padua Padova Italy

Zobrazit více v PubMed

Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.68, 394–424 (2018). 10.3322/caac.21492 PubMed DOI

Jethwa, A. R. & Khariwala, S. S. Tobacco-related carcinogenesis in head and neck cancer. Cancer Metastasis Rev.36, 411–423 (2017). 10.1007/s10555-017-9689-6 PubMed DOI PMC

Boffetta, P., Hecht, S., Gray, N., Gupta, P. & Straif, K. Smokeless tobacco and cancer. lancet Oncol.9, 667–675 (2008). 10.1016/S1470-2045(08)70173-6 PubMed DOI

Gandini, S. et al. Tobacco smoking and cancer: a meta‐analysis. Int. J. Cancer122, 155–164 (2008). 10.1002/ijc.23033 PubMed DOI

Hashibe, M. et al. Evidence for an important role of alcohol-and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol. Biomark. Prev.15, 696–703 (2006).10.1158/1055-9965.EPI-05-0710 PubMed DOI

Hashibe, M. et al. Alcohol drinking in never users of tobacco, cigarette smoking in never drinkers, and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. J. Natl. Cancer Inst.99, 777–789 (2007). 10.1093/jnci/djk179 PubMed DOI

Ang, K. K. et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N. Engl. J. Med.363, 24–35 (2010). 10.1056/NEJMoa0912217 PubMed DOI PMC

Elrefaey, S., Massaro, M., Chiocca, S., Chiesa, F. & Ansarin, M. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol. Italica34, 299 (2014). PubMed PMC

Fakhry, C. et al. Improved survival of patients with human papillomavirus–positive head and neck squamous cell carcinoma in a prospective clinical trial. J. Natl Cancer Inst.100, 261–269 (2008). 10.1093/jnci/djn011 PubMed DOI

Kreimer, A. R. et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J. Clin. Oncol.31, 2708 (2013). 10.1200/JCO.2012.47.2738 PubMed DOI PMC

Lang Kuhs, K. A. et al. Human papillomavirus 16 E6 antibodies in individuals without diagnosed cancer: a pooled analysis. Cancer Epidemiol. Biomark. Prev.24, 683–689 (2015).10.1158/1055-9965.EPI-14-1217 PubMed DOI PMC

Lydiatt, W. M. et al. Head and Neck cancers-major changes in the American Joint Committee on cancer eighth edition cancer staging manual. CA Cancer J. Clin.67, 122–137 (2017). 10.3322/caac.21389 PubMed DOI

Anantharaman, D. et al. Combined effects of smoking and HPV16 in oropharyngeal cancer. Int. J. Epidemiol.45, 752–761 (2016). 10.1093/ije/dyw069 PubMed DOI PMC

Skoulakis, A. et al. Do smoking and human papilloma virus have a synergistic role in the development of head and neck cancer? A systematic review and meta-analysis. J. BUON25, 1107–1115 (2020). PubMed

Arif, R. T., Mogaddam, M. A., Merdad, L. A. & Farsi, N. J. Does human papillomavirus modify the risk of oropharyngeal cancer related to smoking and alcohol drinking? A systematic review and meta-analysis. Laryngoscope Investig. Otolaryngol.7, 1391–1401 (2022). 10.1002/lio2.877 PubMed DOI PMC

Sanderson, E. et al. Mendelian randomization. Nat. Rev. Methods Prim.2, 6 (2022).10.1038/s43586-021-00092-5 PubMed DOI PMC

de Leeuw, C., Savage, J., Bucur, I. G., Heskes, T. & Posthuma, D. Understanding the assumptions underlying Mendelian randomization. Eur. J. Hum. Genet.30, 653–660 (2022). 10.1038/s41431-022-01038-5 PubMed DOI PMC

Sanderson, E. Multivariable Mendelian randomization and mediation. Cold Spring Harb. Perspect. Med.11, a038984 (2021). 10.1101/cshperspect.a038984 PubMed DOI PMC

Auguste, A. et al. Joint effect of tobacco, alcohol, and oral HPV infection on head and neck cancer risk in the French West Indies. Cancer Med.9, 6854–6863 (2020). 10.1002/cam4.3327 PubMed DOI PMC

Liu, M. et al. Data related to association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat. Genet.51, 237–244 (2019). PubMed PMC

Furberg, H. et al. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat. Genet.42, 441–447 (2010). 10.1038/ng.571 PubMed DOI PMC

Lesseur, C. et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat. Genet.48, 1544–1550 (2016). 10.1038/ng.3685 PubMed DOI PMC

Gormley, M. et al. A multivariable Mendelian randomization analysis investigating smoking and alcohol consumption in oral and oropharyngeal cancer. Nat. Commun.11, 6071 (2020). 10.1038/s41467-020-19822-6 PubMed DOI PMC

Karlsson Linnér, R. et al. Genome-wide association analyses of risk tolerance and risky behaviors in over 1 million individuals identify hundreds of loci and shared genetic influences. Nat. Genet.51, 245–257 (2019). 10.1038/s41588-018-0309-3 PubMed DOI PMC

Cogliano, V. J. et al. Preventable exposures associated with human cancers. J. Natl Cancer Inst.103, 1827–1839 (2011). 10.1093/jnci/djr483 PubMed DOI PMC

Hashibe, M. et al. Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium. Cancer Epidemiol. Biomark. Prev.18, 541–550 (2009).10.1158/1055-9965.EPI-08-0347 PubMed DOI PMC

Vineis, P. et al. Tobacco and cancer: recent epidemiological evidence. J. Natl Cancer Inst.96, 99–106 (2004). 10.1093/jnci/djh014 PubMed DOI

Sturgis, E. M. & Ang, K. K. The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J. Natl Compr. Canc Netw.9, 665–673 (2011). 10.6004/jnccn.2011.0055 PubMed DOI

Eldridge, R. C. et al. Smoking and subsequent human papillomavirus infection: a mediation analysis. Ann. Epidemiol.27, 724–730.e721 (2017). 10.1016/j.annepidem.2017.10.004 PubMed DOI PMC

Sinha, P., Logan, H. L. & Mendenhall, W. M. Human papillomavirus, smoking, and head and neck cancer. Am. J. Otolaryngol.33, 130–136 (2012). 10.1016/j.amjoto.2011.02.001 PubMed DOI PMC

Rees, J. M., Foley, C. N. & Burgess, S. Factorial Mendelian randomization: using genetic variants to assess interactions. Int. J. Epidemiol.49, 1147–1158 (2020). 10.1093/ije/dyz161 PubMed DOI PMC

Ference, B. A., Majeed, F., Penumetcha, R., Flack, J. M. & Brook, R. D. Effect of naturally random allocation to lower low-density lipoprotein cholesterol on the risk of coronary heart disease mediated by polymorphisms in NPC1L1, HMGCR, or both: a 2× 2 factorial Mendelian randomization study. J. Am. Coll. Cardiol.65, 1552–1561 (2015). 10.1016/j.jacc.2015.02.020 PubMed DOI PMC

Ference, B. A. et al. Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes. N. Engl. J. Med.375, 2144–2153 (2016). 10.1056/NEJMoa1604304 PubMed DOI

Davies, N. M., Holmes, M. V. & Davey Smith, G. Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ362, k601 (2018). 10.1136/bmj.k601 PubMed DOI PMC

Heck, J. E. et al. Sexual behaviours and the risk of head and neck cancers: a pooled analysis in the International Head and Neck Cancer Epidemiology (INHANCE) consortium. Int. J. Epidemiol.39, 166–181 (2010). 10.1093/ije/dyp350 PubMed DOI PMC

Gormley, M. et al. Investigating the effect of sexual behaviour on oropharyngeal cancer risk: a methodological assessment of Mendelian randomization. BMC Med.20, 40 (2022). 10.1186/s12916-022-02233-3 PubMed DOI PMC

Budhathoki, S. et al. A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markers. Int. J. Cancer152, 2069–2080 (2023). 10.1002/ijc.34444 PubMed DOI PMC

Castellsagué, X. et al. HPV involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J. Natl Cancer Inst.108, djv403 (2016). 10.1093/jnci/djv403 PubMed DOI

Ferreiro-Iglesias, A. et al. Germline determinants of humoral immune response to HPV-16 protect against oropharyngeal cancer. Nat. Commun.12, 5945 (2021). 10.1038/s41467-021-26151-9 PubMed DOI PMC

Chi, A. C., Day, T. A. & Neville, B. W. Oral cavity and oropharyngeal squamous cell carcinoma–an update. CA Cancer J. Clin.65, 401–421 (2015). 10.3322/caac.21293 PubMed DOI

Combes, J.-D. & Franceschi, S. Role of human papillomavirus in non-oropharyngeal head and neck cancers. Oral. Oncol.50, 370–379 (2014). 10.1016/j.oraloncology.2013.11.004 PubMed DOI

Mirghani, H., Amen, F., Moreau, F. & Lacau St Guily, J. Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma? Oral. Oncol.51, 229–236 (2015). 10.1016/j.oraloncology.2014.11.011 PubMed DOI

Consortium, O. Consortium launches genotyping effort. Cancer Discov.3, 1321–1322 (2013). PubMed

Mailman, M. D. et al. The NCBI dbGaP database of genotypes and phenotypes. Nat. Genet.39, 1181–1186 (2007). 10.1038/ng1007-1181 PubMed DOI PMC

Wrayner, N. (Accessed 09/20/2021). Strand. Wellcome Centre for Human Genetics. https://www.well.ox.ac.uk/~wrayner/strand/.

Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet.81, 559–575 (2007). 10.1086/519795 PubMed DOI PMC

Patterson, N., Price, A. L. & Reich, D. Population Structure and Eigenanalysis. PLOS Genet.2, e190 (2006). 10.1371/journal.pgen.0020190 PubMed DOI PMC

Price, A. L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet.38, 904–909 (2006). 10.1038/ng1847 PubMed DOI

Das, S. et al. Next-generation genotype imputation service and methods. Nat. Genet.48, 1284–1287 (2016). 10.1038/ng.3656 PubMed DOI PMC

Loh, P.-R. et al. Reference-based phasing using the Haplotype Reference Consortium panel. Nat. Genet.48, 1443–1448 (2016). 10.1038/ng.3679 PubMed DOI PMC

Fuchsberger, C., Abecasis, G. R. & Hinds, D. A. minimac2: faster genotype imputation. Bioinformatics31, 782–784 (2015). 10.1093/bioinformatics/btu704 PubMed DOI PMC

Leffondré, K., Abrahamowicz, M., Xiao, Y. & Siemiatycki, J. Modelling smoking history using a comprehensive smoking index: application to lung cancer. Stat. Med.25, 4132–4146 (2006). 10.1002/sim.2680 PubMed DOI

Wootton, R. E. et al. Evidence for causal effects of lifetime smoking on risk for depression and schizophrenia: a Mendelian randomisation study. Psychol. Med.50, 2435 (2020). 10.1017/S0033291719002678 PubMed DOI PMC

Prentice, R. L., Vollmer, W. M. & Kalbfleisch, J. D. On the use of case series to identify disease risk factors. Biometrics4, 445-458 (1984). PubMed

Hemani, G. et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife7, e34408 (2018). 10.7554/eLife.34408 PubMed DOI PMC

Bowden, J., Davey Smith, G. & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol.44, 512–525 (2015). 10.1093/ije/dyv080 PubMed DOI PMC

Bowden, J., Davey Smith, G., Haycock, P. C. & Burgess, S. Consistent estimation in mendelian randomization with some invalid instruments using a weighted median estimator. Genet. Epidemiol.40, 304–314 (2016). 10.1002/gepi.21965 PubMed DOI PMC

Verbanck, M., Chen, C.-Y., Neale, B. & Do, R. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat. Genet.50, 693–698 (2018). 10.1038/s41588-018-0099-7 PubMed DOI PMC

Rees, J. M. B., Wood, A. M. & Burgess, S. Extending the MR-Egger method for multivariable Mendelian randomization to correct for both measured and unmeasured pleiotropy. Stat. Med.36, 4705–4718 (2017). 10.1002/sim.7492 PubMed DOI PMC

Burgess, S. & Thompson, S. G. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am. J. Epidemiol.181, 251–260 (2015). 10.1093/aje/kwu283 PubMed DOI PMC

Mariosa, D. et al. Body size at different ages and risk of 6 cancers: a Mendelian randomization and prospective cohort study. J. Natl Cancer Inst.114, 1296–1300 (2022). 10.1093/jnci/djac061 PubMed DOI PMC

Sanderson, E., Spiller, W. & Bowden, J. Testing and correcting for weak and pleiotropic instruments in two‐sample multivariable Mendelian randomization. Stat. Med.40, 5434–5452 (2021). 10.1002/sim.9133 PubMed DOI PMC

Kleiber, C. & Zeileis, A. Applied econometrics with R. (Springer Science & Business Media, 2008).

Thrakal, A. et al. mrhnscc/MRHNSCC: v1 (Version v1). Zenodo. 10.5281/zenodo.12558118 (2024).

VOYAGER: an international consortium investigating the role of human papilloma virus and genetics in oral and oropharyngeal cancer risk and survival